Behzad Baradaran

155PUBLICATIONS
213CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (155)

|Aug 04, 2026
RETRACTED: Safaee et al. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines. Molecules 2021, 26, 901.

|Jul 08, 2026
Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest.

|Jul 04, 2026
Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies.

|Jun 16, 2026
Photodynamic therapy enhances dacarbazine sensitivity of melanoma cells by induction of apoptosis and downregulation of PI3K/AKT signaling pathway.

|Mar 16, 2026
Mebendazole-Treated Human Monocyte-Derived Dendritic Cells Represent Promoted Immunogenic Phenotype with Augmented Expression of Inflammatory Markers.

Shiva Alipour, Sepideh Sohrabi, Amirhossein Mardi

|Feb 14, 2026
Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges.

Jamal Motallebzadeh Khanmiri, Mohammad Khani-Eshratabadi, Fatemeh Seyedmoharrami

Pageof 26

Frequent Collaborators

32 joint publications

Behzad Mansoori

23 joint publications

Nicola Silvestris

20 joint publications

Afshin Derakhshani

14 joint publications

Ali Mohammadi